Zimmer Biomet Holdings Income After Taxes 2010-2024 | ZBH
Zimmer Biomet Holdings annual/quarterly income after taxes history and growth rate from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
- Zimmer Biomet Holdings income after taxes for the quarter ending December 31, 2024 was $0.240B, a 42.82% decline year-over-year.
- Zimmer Biomet Holdings income after taxes for the twelve months ending December 31, 2024 was $0.905B, a 11.71% decline year-over-year.
- Zimmer Biomet Holdings annual income after taxes for 2024 was $0.905B, a 11.7% decline from 2023.
- Zimmer Biomet Holdings annual income after taxes for 2023 was $1.025B, a 252.03% increase from 2022.
- Zimmer Biomet Holdings annual income after taxes for 2022 was $0.291B, a 34.64% decline from 2021.
| Zimmer Biomet Holdings Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2024 | $905 |
| 2023 | $1,025 |
| 2022 | $291 |
| 2021 | $446 |
| 2020 | $-9 |
| 2019 | $1,132 |
| 2018 | $-379 |
| 2017 | $1,813 |
| 2016 | $305 |
| 2015 | $146 |
| 2014 | $719 |
| 2013 | $779 |
| 2012 | $753 |
| 2011 | $760 |
| 2010 | $597 |
| 2009 | $717 |
| Zimmer Biomet Holdings Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2024-12-31 | $240 |
| 2024-09-30 | $249 |
| 2024-06-30 | $243 |
| 2024-03-31 | $173 |
| 2023-12-31 | $420 |
| 2023-09-30 | $163 |
| 2023-06-30 | $210 |
| 2023-03-31 | $233 |
| 2022-12-31 | $-130 |
| 2022-09-30 | $194 |
| 2022-06-30 | $154 |
| 2022-03-31 | $73 |
| 2021-12-31 | $-55 |
| 2021-09-30 | $162 |
| 2021-06-30 | $145 |
| 2021-03-31 | $193 |
| 2020-12-31 | $462 |
| 2020-09-30 | $246 |
| 2020-06-30 | $-208 |
| 2020-03-31 | $-509 |
| 2019-12-31 | $321 |
| 2019-09-30 | $432 |
| 2019-06-30 | $132 |
| 2019-03-31 | $246 |
| 2018-12-31 | $-903 |
| 2018-09-30 | $162 |
| 2018-06-30 | $185 |
| 2018-03-31 | $176 |
| 2017-12-31 | $1,231 |
| 2017-09-30 | $99 |
| 2017-06-30 | $184 |
| 2017-03-31 | $299 |
| 2016-12-31 | $70 |
| 2016-09-30 | $158 |
| 2016-06-30 | $-32 |
| 2016-03-31 | $109 |
| 2015-12-31 | $127 |
| 2015-09-30 | $22 |
| 2015-06-30 | $-174 |
| 2015-03-31 | $171 |
| 2014-12-31 | $149 |
| 2014-09-30 | $173 |
| 2014-06-30 | $176 |
| 2014-03-31 | $221 |
| 2013-12-31 | $255 |
| 2013-09-30 | $154 |
| 2013-06-30 | $152 |
| 2013-03-31 | $218 |
| 2012-12-31 | $152 |
| 2012-09-30 | $178 |
| 2012-06-30 | $214 |
| 2012-03-31 | $209 |
| 2011-12-31 | $156 |
| 2011-09-30 | $191 |
| 2011-06-30 | $204 |
| 2011-03-31 | $209 |
| 2010-12-31 | $35 |
| 2010-09-30 | $191 |
| 2010-06-30 | $166 |
| 2010-03-31 | $205 |
| 2009-12-31 | $155 |
| 2009-09-30 | $150 |
| 2009-06-30 | $210 |
| 2009-03-31 | $202 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $20.443B | $7.679B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $222.392B | 27.46 |
| Boston Scientific (BSX) | United States | $154.781B | 41.84 |
| Stryker (SYK) | United States | $150.988B | 32.49 |
| EssilorLuxottica (ESLOY) | France | $128.761B | 0.00 |
| Medtronic (MDT) | Ireland | $116.457B | 17.30 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.724B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.049B | 27.97 |
| Agilent Technologies (A) | United States | $42.120B | 27.91 |
| GE HealthCare Technologies (GEHC) | United States | $40.456B | 20.98 |
| ResMed (RMD) | United States | $34.834B | 26.83 |
| Terumo (TRUMY) | Japan | $27.701B | 39.39 |
| Koninklijke Philips (PHG) | Netherlands | $25.801B | 19.75 |
| Insulet (PODD) | United States | $20.179B | 80.36 |
| Baxter (BAX) | United States | $15.731B | 10.24 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.039B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.976B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.951B | 37.15 |
| Bio-Rad Laboratories (BIO) | United States | $9.670B | 32.87 |
| Demant (WILYY) | Denmark | $7.946B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.320B | 14.69 |
| Prestige Consumer Healthcare (PBH) | United States | $4.316B | 20.65 |
| ICU Medical (ICUI) | United States | $3.878B | 36.92 |
| Envista Holdings (NVST) | United States | $3.750B | 29.85 |
| Perrigo (PRGO) | Ireland | $3.407B | 10.03 |
| Haemonetics (HAE) | United States | $3.164B | 14.89 |
| GN Store Nord (GNNDY) | Denmark | $3.123B | 21.05 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.832B | 18.23 |
| Neogen (NEOG) | United States | $2.315B | 26.67 |
| LeMaitre Vascular (LMAT) | United States | $2.245B | 54.55 |
| AtriCure (ATRC) | United States | $1.997B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.513B | 26.48 |
| AdaptHealth (AHCO) | United States | $1.300B | 9.29 |
| InMode (INMD) | Israel | $1.269B | 10.61 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.250B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.215B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.069B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.996B | 15.27 |
| Evolus (EOLS) | United States | $0.849B | 0.00 |
| CeriBell (CBLL) | United States | $0.810B | 0.00 |
| Owens & Minor (OMI) | United States | $0.667B | 5.21 |
| Capricor Therapeutics (CAPR) | United States | $0.652B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.627B | 27.14 |
| Valneva SE (VALN) | France | $0.563B | 0.00 |
| Omeros (OMER) | United States | $0.526B | 0.00 |
| SNDL (SNDL) | Canada | $0.507B | 0.00 |
| Surmodics (SRDX) | United States | $0.487B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.474B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.424B | 0.00 |
| ZimVie (ZIMV) | United States | $0.383B | 32.26 |
| Canopy Growth (CGC) | Canada | $0.363B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.343B | 62.50 |
| Cerus (CERS) | United States | $0.323B | 0.00 |
| Quanterix (QTRX) | United States | $0.320B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.317B | 30.11 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.292B | 19.55 |
| Biote (BTMD) | United States | $0.261B | 5.73 |
| Zynex (ZYXI) | United States | $0.252B | 52.80 |
| High Tide (HITI) | Canada | $0.238B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.232B | 3.26 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.226B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.209B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.209B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.203B | 15.16 |
| Brainsway (BWAY) | Israel | $0.200B | 106.40 |
| MacroGenics (MGNX) | United States | $0.174B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.164B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.142B | 17.83 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.127B | 0.00 |
| Fonar (FONR) | United States | $0.101B | 11.44 |
| Exagen (XGN) | United States | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| InterCure (INCR) | Israel | $0.080B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.073B | 0.00 |
| INLIF (INLF) | $0.067B | 0.00 | |
| Rockwell Medical (RMTI) | United States | $0.064B | 33.00 |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.055B | 0.00 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| MariMed (MRMD) | United States | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.051B | 14.60 |
| Modular Medical (MODD) | United States | $0.048B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Safety Shot (SHOT) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |